2 Stocks That Could Turn $100 Into $1,000 by 2028
Doing so requires a substantial compound annual growth rate (CAGR) exceeding 58%. You're not likely to see such a rate among value stocks, which for all their consistency rarely grow at that pace. Two companies where I see that kind of progress over the next five years are Vir Biotechnology (NASDAQ: VIR) and Albemarle (NYSE: ALB).